0000927066-17-000094.txt : 20171212 0000927066-17-000094.hdr.sgml : 20171212 20171212195746 ACCESSION NUMBER: 0000927066-17-000094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171208 FILED AS OF DATE: 20171212 DATE AS OF CHANGE: 20171212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZUMWALT LEANNE M CENTRAL INDEX KEY: 0001204946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 171252848 MAIL ADDRESS: STREET 1: C/O THE ADVISORY BOARD CO WATERGATGE STREET 2: 600 NEW HAMPSHIRE AVE NW CITY: WASHINGTON STATE: DC ZIP: 20037 FORMER NAME: FORMER CONFORMED NAME: ZURNWALT LEANNE M DATE OF NAME CHANGE: 20021109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wf-form4_151312665238950.xml FORM 4 X0306 4 2017-12-08 0 0000927066 DAVITA INC. DVA 0001204946 ZUMWALT LEANNE M C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 Grp VP, Purch & Public Affairs Common Stock 2017-12-08 4 M 0 5400 55.34 A 12423 D Common Stock 2017-12-08 4 F 0 4451 67.14 D 7972 D Common Stock 2017-12-08 4 S 0 949 68.1889 D 7023 D Stock Appreciation Rights 55.34 2017-12-08 4 M 0 5400 0 D 2017-12-18 Common Stock 5400.0 0 D Represents the weighted average sale price of $68.1889. The range of prices for the sale of these shares was $68.1700 - $68.2100 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on 12/18/2012. 50% vested on 4/1/2015 and the remaining 50% vested on 4/1/2016. /s/ Arturo Sida, Attorney-in-Fact 2017-12-12